Trademarkia Logo

Australia

AU$
UFRAXTA
Accepted: In opposition period

Last updated on 12 Apr 2025

Owner Info

Larimar Therapeutics, Inc.

Three Bala Plaza East, Suite 506

Bala Cynwyd PA 19004, UNITED STATES OF AMERICA

Serial Number

2536531 filed on 6 Mar 2025

Correspondent

Keith Toms, Esq. McCarter & English, LLP

265 Franklin Street,

Boston MA 02110-3113,

UNITED STATES OF AMERICA

UFRAXTA

Classification Information


Class [005]
Pharmaceutical preparations; pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for Read More

Mark Details


Serial Number

2536531

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

10 Sept 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
12th Apr 2025Application Accepted correspondence sent
11th Apr 2025IP Right has been Examined
11th Apr 2025IP Right Acceptance Published
11th Apr 2025Status change to Accepted
4th Apr 2025Awaiting examination
4th Apr 2025Examination expedited
3rd Apr 2025IP Right Filed Published
3rd Apr 2025Status change to Published
3rd Apr 2025Status change to Filed
3rd Apr 2025Application Received